SCHEMBL9891435

SCHEMBL9891435

CC(C)(C)OC(=O)CCCNc1ccc(S(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.47
ABCC9 O60706 3/20 0.47
ABCC8 Q09428 3/20 0.47
KCNJ11 Q14654 3/20 0.47
KCNJ8 Q15842 3/20 0.47
MEN1 O00255 2/20 0.47
TSHR P16473 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 4/20 0.44
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42
HPGD P15428 2/20 0.41
HSD11B1 P28845 1/20 0.41
MAPT P10636 3/20 0.40
KDM4E B2RXH2 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9891452 0.87 ALDH1A1 (0.48) ALDH1A1CA1CA2MAPTLMNA
SCHEMBL9892803 0.84 CA1 (0.45) ALDH1A1CA1CA2CA12CA9
SCHEMBL9891445 0.82 PDK1 (0.47) KMT2AALDH1A1HPGDMAPTGAA
SCHEMBL15613898 0.81 ALDH1A1 (0.63) KMT2AMEN1TSHRALDH1A1CA1
SCHEMBL9891433 0.80 HDAC8 (0.42) KMT2AMEN1ALDH1A1CA1CA2
SCHEMBL5151596 0.78 POLB (0.44) ALDH1A1CA1CA2CA12CA9
SCHEMBL9891447 0.78 MAPT (0.53) ALDH1A1MAPTGAA
SCHEMBL9891440 0.78 HDAC8 (0.46) ALDH1A1CA1CA2MAPTKDM4E
SCHEMBL16369813 0.78 POLB (0.42) CYP1A2CYP3A4CA1CA2MAPT
SCHEMBL9891441 0.78 POLB (0.42) CYP1A2CYP3A4ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921026-B2 Basic compound, chemically amplified resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-12-30 US disclosed
US-8921026-B2 Basic compound, chemically amplified resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-12-30 US disclosed
EP-2463714-B1 Basic compound, chemically amplified resist composition and patterning process SHINETSU CHEMICAL CO (JP) 2013-08-28 EP disclosed
EP-2463714-A1 Basic compound, chemically amplified resist composition and patterning process Shin-Etsu Chemical Co., Ltd. (JP) 2012-06-13 EP disclosed
US-20120141938-A1 BASIC COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-06-07 US disclosed
US-20120141938-A1 BASIC COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120141938-A1 BASIC COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS GABRA5, GABRB1, GABBR1 KMT2A 939/4885ABCC9 4176/4885ABCC8 4507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.